Crossing the Blues
Showing posts with label . News. Show all posts
Showing posts with label . News. Show all posts
05. Iran

Crude production: 4.2 million barrels per day
Share of world production: 4.9%
Daily crude exports to the US: 0
Proven reserves: 137.6 billion barrels

04. China

Crude production: 4.26 million barrels per day
Share of world production: 5.0%
Daily crude exports to the US: 8,000 barrels
Proven reserves: 20.4 billion barrels

03. United States

Crude production: 8.85 million barrels per day
Share of world production: 10.4%
Total crude imports: 8.63 million barrels per day
Proven reserves: 19.2 billion barrels

02. Russia

Crude production: 9.91 million barrels per day
Share of world production: 11.6%
Daily crude exports to the US: 158,000 barrels
Proven reserves: 60 billion barrels

01. Saudi Arabia

Crude production: 10.3 million barrels per day
Share of world production: 12.1%
Daily crude exports to the US: 1.08 million barrels
Proven reserves: 259.9 billion barrels

Robert Downey Jr.
Robert Downey Jr. is making plans to fill the fall hole in his schedule with the lead role in Inherent Vice for writer-directorPaul Thomas Anderson.
Anderson has been working on a screenplay adaptation of the 2009Thomas Pynchon novel while trying to get another film -- an untitled exploration of a religious organization sometimes referred to as The Master -- off the ground. Once Downey dropped out of Disney's Oz, the Great and Powerful last month, it freed him to do another movie later this year after he shoots The Avengers for Marvel and Disney. His commitment to Anderson's movie has recently grown serious.
Vice is a comparatively accessible Pynchon work that tells the story of a stoner detective who gets wrapped up in a number of mysteries in 1969 L.A. while the Manson Family trial growls in the background.
Downey, who last starred in Due Date and Iron Man 2, has wrapped filming on Sherlock Holmes: A Game of Shadows for director Guy Ritchie and Warner Bros. That sequel comes out in December. The actor has a number of projects in development at his Team Downey shingle, plus Iron Man 3 to film for Marvel and Disney in time for a summer 2013 release. Avengers is scheduled to begin shooting in the coming months.
Anderson last wrote and directed There Will Be Blood, which grossed $76 million worldwide in 2007. He has spent the last few years developing The Master for Philip Seymour Hoffman to star, and now he is trying to secure financing for both films.
Both Anderson and Downey are repped by CAA, which declined to comment.

Robert Downey Jr.
Robert Downey Jr. is making plans to fill the fall hole in his schedule with the lead role in Inherent Vice for writer-directorPaul Thomas Anderson.
Anderson has been working on a screenplay adaptation of the 2009Thomas Pynchon novel while trying to get another film -- an untitled exploration of a religious organization sometimes referred to as The Master -- off the ground. Once Downey dropped out of Disney's Oz, the Great and Powerful last month, it freed him to do another movie later this year after he shoots The Avengers for Marvel and Disney. His commitment to Anderson's movie has recently grown serious.
Vice is a comparatively accessible Pynchon work that tells the story of a stoner detective who gets wrapped up in a number of mysteries in 1969 L.A. while the Manson Family trial growls in the background.
Downey, who last starred in Due Date and Iron Man 2, has wrapped filming on Sherlock Holmes: A Game of Shadows for director Guy Ritchie and Warner Bros. That sequel comes out in December. The actor has a number of projects in development at his Team Downey shingle, plus Iron Man 3 to film for Marvel and Disney in time for a summer 2013 release. Avengers is scheduled to begin shooting in the coming months.
Anderson last wrote and directed There Will Be Blood, which grossed $76 million worldwide in 2007. He has spent the last few years developing The Master for Philip Seymour Hoffman to star, and now he is trying to secure financing for both films.
Both Anderson and Downey are repped by CAA, which declined to comment.